Medtech Looks to Innovation, New Markets to Offset Pricing Pressure
Raj Denhoy is Managing Director, Equity Research at Jefferies & Company, Inc. Mr. Denhoy joined Jefferies & Company, Inc., in November 2009 as a Senior Equity Research Analyst covering medical technology. Prior to joining the firm, he was a Senior Analyst at Thomas Weisel Partners, Bear Stearns and Piper Jaffray & Co. He has also worked at J.P. Morgan and Banc of America Securities, and has been covering the sector since 1998. Mr. Denhoy holds an MBA from Cornell University, an M.S. from Georgetown University in human physiology, and a B.A. from U.C. Berkeley in biology.
TWST: Where are you focusing your attention in the medical device space these days?
Mr. Denhoy: We continue to follow the space fairly broadly. We follow about 30 stocks, most